Cas:68550-75-4 Cilostamide manufacturer & supplier

Chemical Name:Cilostamide

CAS.NO:68550-75-4

Synonyms:Butanamide, N-cyclohexyl-4-[(1,2-dihydro-2-oxo-6-quinolinyl)oxy]-N-methyl-;N-Cyclohexyl-N-methyl-4-[(2-oxo-1,2-dihydro-6-quinolinyl)oxy]butanamide;MFCD00673958;N-Cyclohexyl-N-methyl-4-[(2-oxo-1,2-dihydroquinolin-6-yl)oxy]butanamide;N-cyclohexyl-N-methyl-4-[(2-oxo-1H-quinolin-6-yl)oxy]butanamide;N-cyclohexyl-4-[(2-hydroxyquinolin-6-yl)oxy]-N-methylbutanamide

Molecular Formula:C₂₀H₂₆N₂O₃

Molecular Weight:342.432

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:594.3±50.0 °C at 760 mmHg

Density:1.2±0.1 g/cm3

Index of Refraction:1.586

PSA:62.40000

Exact Mass:342.194336

LogP:2.70

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:UN 3249

Packing Group:III

Contact us for information like Butanamide, N-cyclohexyl-4-[(1,2-dihydro-2-oxo-6-quinolinyl)oxy]-N-methyl- chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,N-cyclohexyl-4-[(2-hydroxyquinolin-6-yl)oxy]-N-methylbutanamide physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,N-Cyclohexyl-N-methyl-4-[(2-oxo-1,2-dihydroquinolin-6-yl)oxy]butanamide Use and application,N-cyclohexyl-4-[(2-hydroxyquinolin-6-yl)oxy]-N-methylbutanamide technical grade,usp/ep/jp grade.

Related News: Speaking to Sky News, Raab said he could not confirm the ��precise number�� of those arriving into the UK on Sunday. Cilostamide manufacturer As part of the agreement, ICIG will enter into a 5-year supply contract to provide Genzyme with materials needed for the production of eliglustat tartrate, an investigational treatment for Gaucher disease Type 1 that is currently in Phase III clinical trials. Cilostamide supplier Russia, which had temporarily stopped issuing work visas to Chinese citizens, is also halting visa-free entry for Chinese tour groups, the government said. Moscow has also stopped issuing electronic tourist visas to individual Chinese travelers. Cilostamide vendor As part of the agreement, ICIG will enter into a 5-year supply contract to provide Genzyme with materials needed for the production of eliglustat tartrate, an investigational treatment for Gaucher disease Type 1 that is currently in Phase III clinical trials. Cilostamide factory Though Innova previously applied for a regulatory green light, the test has not been authorized or approved by the FDA for use in the U.S.—however, during inspections of the company’s California facilities in March and April, FDA investigators said they found the test was already being sold and distributed.